NO20092101L - Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav. - Google Patents

Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav.

Info

Publication number
NO20092101L
NO20092101L NO20092101A NO20092101A NO20092101L NO 20092101 L NO20092101 L NO 20092101L NO 20092101 A NO20092101 A NO 20092101A NO 20092101 A NO20092101 A NO 20092101A NO 20092101 L NO20092101 L NO 20092101L
Authority
NO
Norway
Prior art keywords
methods
ocular devices
manufacture
devices
ocular
Prior art date
Application number
NO20092101A
Other languages
English (en)
Inventor
Lynn Cook Winterton
John Dallas Pruitt
John Martin Lally
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20092101L publication Critical patent/NO20092101L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Beskrevet heri er stabile okulære innretninger som immobiliserer og leverer vedvarende bioaktive midler til øyet over tid. Også beskrevet heri er fremgangsmåter for fremstiling og anvendelse av de okulære innretningene.
NO20092101A 2006-11-06 2009-05-28 Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav. NO20092101L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86442806P 2006-11-06 2006-11-06
PCT/US2007/023239 WO2008073193A2 (en) 2006-11-06 2007-11-05 Ocular devices and methods of making and using thereof

Publications (1)

Publication Number Publication Date
NO20092101L true NO20092101L (no) 2009-06-05

Family

ID=39284102

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092101A NO20092101L (no) 2006-11-06 2009-05-28 Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav.

Country Status (15)

Country Link
US (1) US20080124376A1 (no)
EP (1) EP2094235A2 (no)
JP (1) JP5586956B2 (no)
KR (1) KR101454041B1 (no)
CN (1) CN101534793A (no)
AR (1) AR063561A1 (no)
AU (1) AU2007332930B2 (no)
BR (1) BRPI0718543A2 (no)
CA (2) CA2914805C (no)
MX (1) MX2009004365A (no)
NO (1) NO20092101L (no)
RU (1) RU2450802C2 (no)
TW (1) TWI476022B (no)
WO (1) WO2008073193A2 (no)
ZA (1) ZA200901842B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090088846A1 (en) 2007-04-17 2009-04-02 David Myung Hydrogel arthroplasty device
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
AU2009246520B2 (en) 2008-05-12 2012-04-19 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US20120209396A1 (en) 2008-07-07 2012-08-16 David Myung Orthopedic implants having gradient polymer alloys
TWI531362B (zh) 2008-07-21 2016-05-01 艾爾康股份有限公司 具有治療劑遞送能力之眼科裝置
JP5721267B2 (ja) 2008-07-21 2015-05-20 ノバルティス アーゲー シリコーンハイドロゲルコンタクトレンズを製造する方法
KR20110040969A (ko) 2008-08-05 2011-04-20 바이오미메디카, 인코포레이티드 폴리우레탄-그라프트된 하이드로겔
TWI506333B (zh) 2008-12-05 2015-11-01 Novartis Ag 用以傳遞疏水性舒適劑之眼用裝置及其製造方法
JP5890182B2 (ja) 2009-02-12 2016-03-22 インセプト エルエルシー ヒドロゲルプラグによる薬物送達
JP5247597B2 (ja) 2009-06-03 2013-07-24 株式会社シード 湿潤性ハイドロゲルコンタクトレンズ及びその製造方法
US9522980B2 (en) 2010-05-06 2016-12-20 Johnson & Johnson Vision Care, Inc. Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same
US8480227B2 (en) 2010-07-30 2013-07-09 Novartis Ag Silicone hydrogel lenses with water-rich surfaces
AU2011293169A1 (en) 2010-08-27 2013-03-21 Biomimedica, Inc. Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same
US20130203813A1 (en) 2011-05-04 2013-08-08 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
US9170349B2 (en) 2011-05-04 2015-10-27 Johnson & Johnson Vision Care, Inc. Medical devices having homogeneous charge density and methods for making same
CN106896422B (zh) 2011-06-09 2021-03-23 爱尔康公司 具有纳米纹理化表面的硅氧烷水凝胶透镜
CN104053458B (zh) * 2011-07-20 2016-07-20 布莱阿姆青年大学 包含洗脱塞拉集宁化合物的水凝胶材料
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
EP3357518B1 (en) 2011-10-03 2020-12-02 Hyalex Orthopaedics, Inc. Polymeric adhesive for anchoring compliant materials to another surface
WO2013078284A1 (en) 2011-11-21 2013-05-30 Biomimedica, Inc. Systems, devices, and methods for anchoring orthopaedic implants to bone
US10039285B2 (en) 2012-05-02 2018-08-07 Brigham Young University Ceragenin particulate materials and methods for making same
US10073192B2 (en) 2012-05-25 2018-09-11 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9244196B2 (en) 2012-05-25 2016-01-26 Johnson & Johnson Vision Care, Inc. Polymers and nanogel materials and methods for making and using the same
US9297929B2 (en) 2012-05-25 2016-03-29 Johnson & Johnson Vision Care, Inc. Contact lenses comprising water soluble N-(2 hydroxyalkyl) (meth)acrylamide polymers or copolymers
WO2014038004A1 (ja) * 2012-09-05 2014-03-13 株式会社メニコン 薬物徐放性眼用レンズ及びその製造方法
HUE031702T2 (en) 2012-12-17 2017-07-28 Novartis Ag A method for producing improved UV absorbing ophthalmic lenses
US9498035B2 (en) 2012-12-21 2016-11-22 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses for sustained release of beneficial polymers
US9161598B2 (en) 2012-12-21 2015-10-20 Coopervision International Holding Company, Lp Ophthalmic devices for delivery of beneficial agents
US9248928B2 (en) 2012-12-21 2016-02-02 Coopervision International Holding Company, Lp Methods of manufacturing contact lenses for delivery of beneficial agents
JP6294352B2 (ja) 2013-01-07 2018-03-14 ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍ Ｙｏｕｎｇ Ｕｎｉｖｅｒｓｉｔｙ 細胞増殖を減少させ、ある特定の疾患を治療する方法
SG2013091087A (en) * 2013-01-09 2014-08-28 Johnson & Johnson Vision Care Multi-piece insert device with glue seal for ophthalmic devices
PT2950783T (pt) * 2013-02-01 2019-08-21 Allergan Inc Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
WO2015048223A2 (en) * 2013-09-27 2015-04-02 Novartis Ag Compositions and methods for disinfecting and cleaning contact lenses
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
HUE038809T2 (hu) 2013-12-17 2018-11-28 Novartis Ag Térhálósított hidrofíl bevonattal ellátott szilikon hidrogél lencse
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
MY183678A (en) 2014-08-26 2021-03-08 Alcon Inc Method for applying stable coating on silicone hydrogel contact lenses
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US11077228B2 (en) 2015-08-10 2021-08-03 Hyalex Orthopaedics, Inc. Interpenetrating polymer networks
KR102604468B1 (ko) 2015-12-15 2023-11-22 알콘 인코포레이티드 실리콘 하이드로겔 콘택트 렌즈 상에 안정한 코팅을 적용하기 위한 방법
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
CN117492228A (zh) 2017-12-13 2024-02-02 爱尔康公司 周抛和月抛水梯度接触镜片
US10869950B2 (en) 2018-07-17 2020-12-22 Hyalex Orthopaedics, Inc. Ionic polymer compositions
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
US12393057B2 (en) 2020-12-15 2025-08-19 Coopervision International Limited Oleic acid-releasing contact lens
US20240118559A1 (en) * 2022-09-27 2024-04-11 Coopervision International Limited Sustained release of oleic acid from contact lenses

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128305C (no) * 1963-09-11
FR2402525A1 (fr) * 1977-09-12 1979-04-06 Toray Industries Procede de fabrication de compositions de lentilles de contact molles et nouveaux produits ainsi obtenus
US4444711A (en) * 1981-12-21 1984-04-24 Husky Injection Molding Systems Ltd. Method of operating a two-shot injection-molding machine
US4460534A (en) * 1982-09-07 1984-07-17 International Business Machines Corporation Two-shot injection molding
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
CA1328151C (en) * 1987-11-09 1994-04-05 David Gibson Implantation of prosthetic devices
EP0336986B1 (en) * 1988-04-09 1992-10-07 Hewlett-Packard GmbH Polyacrylamide gels
US4983702A (en) * 1988-09-28 1991-01-08 Ciba-Geigy Corporation Crosslinked siloxane-urethane polymer contact lens
JP3085480B2 (ja) * 1991-10-02 2000-09-11 セイコーエプソン株式会社 ホルモン徐放性コンタクトレンズ
TW272976B (no) * 1993-08-06 1996-03-21 Ciba Geigy Ag
US5712356A (en) * 1993-11-26 1998-01-27 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
AU1042495A (en) * 1993-12-08 1995-06-27 Vitaphore Corporation Microsphere drug delivery system
US5894002A (en) * 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
US5843346A (en) * 1994-06-30 1998-12-01 Polymer Technology Corporation Method of cast molding contact lenses
US5760100B1 (en) * 1994-09-06 2000-11-14 Ciba Vision Corp Extended wear ophthalmic lens
US5665840A (en) * 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
ATE178414T1 (de) * 1995-02-03 1999-04-15 Novartis Ag Vernetzte polymere enthaltend ester- oder amidgruppen
TW349967B (en) * 1995-02-03 1999-01-11 Novartis Ag Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor
US5583463A (en) * 1995-05-30 1996-12-10 Micron Technology, Inc. Redundant row fuse bank circuit
JP2001502734A (ja) * 1996-10-21 2001-02-27 ノバルティス アクチエンゲゼルシャフト 架橋性ポリマー
TW425403B (en) * 1997-02-04 2001-03-11 Novartis Ag Branched polyurethane (meth)acrylate prepolymers, opthal-mic mouldings derived therefrom and processes for their manufacture
ATE216501T1 (de) * 1997-02-21 2002-05-15 Novartis Erfind Verwalt Gmbh Opthalmische formmasse
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
US6011082A (en) * 1997-06-02 2000-01-04 Pharmacia & Upjohn Ab Process for the modification of elastomers with surface interpreting polymer networks and elastomers formed therefrom
EP1017734B1 (en) * 1997-09-16 2002-08-28 Novartis AG Crosslinkable polyurea polymers
TW429327B (en) * 1997-10-21 2001-04-11 Novartis Ag Single mould alignment
US6039913A (en) * 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
EP1002807A1 (en) * 1998-11-20 2000-05-24 Novartis AG Functionalized resin derived from polyallylamine
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent
AU2001228742A1 (en) * 2000-02-04 2001-08-14 Supratek Pharma, Inc. Ligand for vascular endothelial growth factor receptor
CA2682118A1 (en) * 2000-03-24 2001-09-27 Novartis Ag Crosslinkable or polymerizable prepolymers
AR030341A1 (es) * 2000-08-14 2003-08-20 Novartis Ag Articulos biomedicos moldeados
US6511960B2 (en) * 2001-01-05 2003-01-28 Alphamed Pharmaceuticals Corp Cromolyn for eye and ear infections
US20030020870A1 (en) * 2001-06-27 2003-01-30 Zms, Llc Biomedical molding materials from semi-solid precursors
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
AU2003258609A1 (en) * 2002-08-14 2004-03-03 Novartis Ag Radiation-curable prepolymers
US20040105880A1 (en) * 2002-11-21 2004-06-03 Turner Josephine Sara Interpenetrating polymer network
JP4379778B2 (ja) * 2003-04-03 2009-12-09 株式会社シード 薬物徐放性眼用レンズ
JP4937491B2 (ja) * 2003-04-03 2012-05-23 株式会社シード カチオン性高分子ゲル及びそれを用いた薬物徐放性高分子ゲル
EP1651946A1 (en) * 2003-07-30 2006-05-03 Novartis AG Reflection hologram sensor in contact lens
US7977430B2 (en) * 2003-11-25 2011-07-12 Novartis Ag Crosslinkable polyurea prepolymers
WO2006053777A1 (en) * 2004-11-22 2006-05-26 Novartis Ag Crosslinkable poly(oxyalkylene)-containing polyamide prepolymers
GB0502790D0 (en) * 2005-02-10 2005-03-16 Univ London Pharmacy Solid dispersion of hydrophobic bioactive
US9804295B2 (en) * 2005-05-05 2017-10-31 Novartis Ag Ophthalmic devices for sustained delivery of active compounds

Also Published As

Publication number Publication date
BRPI0718543A2 (pt) 2013-11-12
KR101454041B1 (ko) 2014-10-27
CA2914805A1 (en) 2008-06-19
AU2007332930A1 (en) 2008-06-19
MX2009004365A (es) 2009-05-05
AR063561A1 (es) 2009-02-04
WO2008073193A2 (en) 2008-06-19
RU2450802C2 (ru) 2012-05-20
ZA200901842B (en) 2010-05-26
CA2668576A1 (en) 2008-06-19
KR20090083901A (ko) 2009-08-04
CN101534793A (zh) 2009-09-16
AU2007332930B2 (en) 2011-03-17
RU2009121444A (ru) 2010-12-20
EP2094235A2 (en) 2009-09-02
CA2668576C (en) 2016-03-22
US20080124376A1 (en) 2008-05-29
WO2008073193A3 (en) 2009-03-26
CA2914805C (en) 2017-12-12
JP5586956B2 (ja) 2014-09-10
JP2010508902A (ja) 2010-03-25
TWI476022B (zh) 2015-03-11
TW200826985A (en) 2008-07-01

Similar Documents

Publication Publication Date Title
NO20092101L (no) Okularinnretninger og fremgangsmåter for fremstilling og anvendelse derav.
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
CY1120741T1 (el) Θεραπεια οζωδους σκληρυνσης
CA2711696C (en) Therapeutic compositions for treatment of ocular inflammatory disorders
DK1933869T3 (da) Anvendelse af IL-23- og IL-17-antagonister til behandling af autoimmun øjenbetændelsessygdom
MX2009004883A (es) Piridil sulfoximinas multi-substituidas y su uso como insecticidas.
DK1715865T3 (da) Terapeutisk middel mod hyperlipæmi med pitavastatiner og eicosapentaensyre
BRPI0808775A2 (pt) compostos e composições como moduladores de atividade de gpr119
EP3685783C0 (en) ENDOLUMINAL LASER ABLATION DEVICE FOR VEIN TREATMENT
NI200900093A (es) Compuestos que modulan la actividad de c-fms y/o c-kit y uso de los mismos.
HN2008000311A (es) Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
NO20070330L (no) Retinalderivater og fremgangsmater for anvendelse derav til behandling av synsforstyrrelser
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
TW200745109A (en) Pyrrolo-pyridine kinase modulators
EA201290131A1 (ru) Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний
NI201100152A (es) Métodos para reducir la proliferación y viabilidad de los agentes microbianos
WO2007035473A3 (en) Pharmaceutical delivery device and method for providing ocular treatment
TW200740416A (en) Corneal onlays and related methods
BRPI0912252A2 (pt) dispositivos oftálmicos para liberação controlada de agentes ativos.
MX2009013970A (es) Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
MX389018B (es) Tratamiento de trastornos de adiccion y control de impulsos usando inhibidores de pde7.
DK2350093T3 (da) Substituerede 4,5,6,7-tetrahydrothienopyridiner som KCNQ2/3-modulatorer til behandling af smerte, epilepsi og urininkontinens.
BR112015022161A2 (pt) implante intraocular contendo prostamida
MY170121A (en) Formulations for the treatment of deep tissue pain
BRPI0614397A2 (pt) compostos de pirimidina como moduladores de receptor de serotonina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application